Stock APH ALLIANCE PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Market Closed - London S.E.
Other stock markets
 11:35:08 2024-04-19 am EDT 		5-day change 1st Jan Change
36.85 GBX +0.27% Intraday chart for Alliance Pharma plc -2.12% -9.01%
Feb. 05 Alliance Pharma appoints chair; FireAngel sales down AN
Feb. 05 Alliance Pharma Chair to Step Down; Successor Named MT

Business Summary

Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.

Number of employees: 285

Sales per Business

GBP in Million2021Weight2022Weight Delta
Consumer Healthcare
72.0 %
115 70.7 % 121 72.0 % +4.55%
Prescription Medicines
28.0 %
48 29.3 % 47 28.0 % -2.17%

Sales per region

GBP in Million2021Weight2022Weight Delta
Europe, Middle East and Africa
47.1 %
89 54.6 % 79 47.1 % -11.51%
Asia Pacific and China
35.4 %
48 29.4 % 59 35.4 % +23.23%
Americas
17.5 %
26 15.9 % 29 17.5 % +12.78%

Managers

Managers TitleAgeSince
Peter Butterfield CEO
 Chief Executive Officer 49 10-02-21
Andrew Franklin DFI
 Director of Finance/CFO 58 15-09-27
Jeyan Heper COO
 Chief Operating Officer - 23-01-31
Stephen Martin Kidner CTO
 Chief Tech/Sci/R&D Officer 56 12-12-31
Chris Chrysanthouc LAW
 General Counsel - 16-12-31
Alex Duggan PRN
 Corporate Officer/Principal - 13-12-31
Janice Elizabeth Timberlake HRO
 Human Resources Officer - 10-12-31

Members of the board

Members of the board TitleAgeSince
Peter Butterfield CEO
 Chief Executive Officer 49 10-02-21
Martin Sutherland BRD
 Director/Board Member 55 23-01-31
Richard Jones BRD
 Director/Board Member 57 18-12-31
Eva-Lotta Sjöstedt BRD
 Director/Board Member 57 Nov. 06
Camillo Pane CHM
 Chairman 53 Feb. 18
Andrew Franklin DFI
 Director of Finance/CFO 58 15-09-27
Jeyan Heper COO
 Chief Operating Officer - 23-01-31
Kristof Leon Neirynck BRD
 Director/Board Member 46 21-11-30
Richard McKenzie BRD
 Director/Board Member 52 Nov. 06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 540,399,740 476,934,288 ( 88.26 %) 0 88.26 %

Shareholders

NameEquities%Valuation
DBAY Advisors Ltd.
21.09 %
113,965,220 21.09 % 57 M p
Van Lanschot Kempen Investment Management NV (United Kingdom)
10.21 %
55,157,348 10.21 % 28 M p
Slater Investments Ltd.
8.937 %
48,295,808 8.937 % 24 M p
Van Lanschot Kempen Investment Management NV
8.445 %
45,634,026 8.445 % 23 M p
Rathbones Investment Management Ltd.
4.805 %
25,968,567 4.805 % 13 M p
Fidelity Management & Research Co. LLC
3.635 %
19,644,025 3.635 % 10 M p
Investec Wealth & Investment Ltd.
3.195 %
17,264,547 3.195 % 9 M p
Artemis Investment Management LLP
3.017 %
16,304,802 3.017 % 8 M p
John Dawson
2.998 %
16,200,462 2.998 % 8 M p
RBC Global Asset Management (UK) Ltd.
2.692 %
14,546,460 2.692 % 7 M p

Company contact information

Alliance Pharma Plc

Avonbridge House Bath Road

SN15 2BB, Chippenham

+44 12 4946 6966

http://www.alliancepharma.co.uk
address Alliance Pharma plc(APH)

Group companies

NameCategory and Sector
Alliance Pharmaceuticals Ltd. (United Kingdom)
Logo Alliance Pharmaceuticals Ltd. (United Kingdom)

Alliance Pharmaceuticals Ltd. (United Kingdom)

Pharmaceuticals: MajorHealth Technology

Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Ratings for Alliance Pharma plc

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.3675 GBP
Average target price
0.6743 GBP
Spread / Average Target
+83.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ALLIANCE PHARMA PLC Stock Alliance Pharma plc
-9.35% 248M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.91% 43.54B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+16.96% 21.74B
SANDOZ GROUP AG Stock Sandoz Group AG
+7.87% 13.53B
CIPLA LIMITED Stock Cipla Limited
+7.98% 13.02B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+33.80% 11.28B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-11.05% 6.99B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+7.71% 5.09B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. APH Stock
  4. Company Alliance Pharma plc